Congressman Bryan Steil Faces Scrutiny Over Pharmaceutical Industry Donations and Voting Record
Congressman Bryan Steil is under criticism for his voting record on pharmaceutical-related legislation, which appears to align with the interests of pharmaceutical companies that have contributed significantly to his campaign. According to reports, Steil has received nearly $220,000 in campaign donations from the pharmaceutical industry during his time in Congress. A specific instance highlighted involves a $500 donation from pharma lobbyist Dan Todd on July 1, 2025. Just two days later, Steil voted in favor of the 'One Big Beautiful Bill,' which, according to the Congressional Budget Office, included a provision granting an $8.8 billion benefit to Big Pharma. This bill reportedly weakened Medicare's ability to negotiate drug prices for certain 'orphan drugs.' Additionally, on March 31, 2022, Steil received $1,500 from Robert Wood, a lobbyist for PhRMA, the pharmaceutical industry's trade group. On the same day, Steil voted against the Affordable Insulin Now Act, a measure designed to cap insulin prices at...